Literature DB >> 32504754

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

Fedor Simko1, Russel J Reiter2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32504754     DOI： 10.1016/j.lfs.2020.117902

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  8 in total

1.  What if melatonin could help patients with severe COVID-19?

Authors:  Miguel Ángel Sánchez-González; Ignacio Mahíllo-Fernández; Felipe Villar-Álvarez; Lucía Llanos
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

Review 2.  Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals.

Authors:  Emmanuel Sunday Okeke; Martins Obinna Ogugofor; Ndidi Ethel Nkwoemeka; Ekene John Nweze; Charles Obinwanne Okoye
Journal:  Microbes Infect       Date:  2021-09-15       Impact factor: 2.700

Review 3.  Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection.

Authors:  Russel J Reiter; Ramaswamy Sharma; Fedor Simko; Alberto Dominguez-Rodriguez; Jan Tesarik; Richard L Neel; Andrzej T Slominski; Konrad Kleszczynski; Verna M Martin-Gimenez; Walter Manucha; Daniel P Cardinali
Journal:  Cell Mol Life Sci       Date:  2022-02-20       Impact factor: 9.207

Review 4.  The Reserve/Maximum Capacity of Melatonin's Synthetic Function for the Potential Dimorphism of Melatonin Production and Its Biological Significance in Mammals.

Authors:  Dun-Xian Tan; Rüdiger Hardeland
Journal:  Molecules       Date:  2021-12-02       Impact factor: 4.411

Review 5.  Melatonin in Early Treatment for COVID-19: A Narrative Review of Current Evidence and Possible Efficacy.

Authors:  Kristina M Cross; Dylan M Landis; Laveena Sehgal; J Drew Payne
Journal:  Endocr Pract       Date:  2021-06-10       Impact factor: 3.443

Review 6.  Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19.

Authors:  Dun-Xian Tan; Ruediger Hardeland
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

Review 7.  Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality.

Authors:  Dun-Xian Tan; Russel J Reiter
Journal:  Life Sci       Date:  2022-01-30       Impact factor: 6.780

8.  Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.

Authors:  Suvojit Hazra; Alok Ghosh Chaudhuri; Basant K Tiwary; Nilkanta Chakrabarti
Journal:  Life Sci       Date:  2020-07-15       Impact factor: 6.780
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.